Impact BioMedical
IBO----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Impact BioMedical(IBO) the Revenue is 7 K (--%);the EBIT is -2.289 M (-126.6%);the EPS is -0.0212 (+80.71%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B--
----
----
EBIT
-0.00B126.63%
----
----
EPS
-0.021280.71%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf